Preferred Name | Pirbuterol Acetate | |
Synonyms |
|
|
Definitions |
The acetate salt form of pirbuterol, a synthetic catecholamine and a pyridine derivative with sympathomimetic and bronchodilatory effects. Pirbuterol acetate selectively stimulates beta-2 adrenergic receptors, resulting in initiation of intracellular adenylate cyclase activity leading to increased levels of cAMP. As a result muscle relaxation (broncho- and vasodilation) occurs via cAMP-dependent signal transduction. In addition, elevated levels of cAMP inhibit release of inflammatory mediators from mast cells. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C47675 |
|
CAS_Registry |
65652-44-0 |
|
Chemical_Formula |
C12H20N2O3.C2H4O2 |
|
code |
C47675 |
|
Contributing_Source |
FDA |
|
definition |
The acetate salt form of pirbuterol, a synthetic catecholamine and a pyridine derivative with sympathomimetic and bronchodilatory effects. Pirbuterol acetate selectively stimulates beta-2 adrenergic receptors, resulting in initiation of intracellular adenylate cyclase activity leading to increased levels of cAMP. As a result muscle relaxation (broncho- and vasodilation) occurs via cAMP-dependent signal transduction. In addition, elevated levels of cAMP inhibit release of inflammatory mediators from mast cells. |
|
FDA_UNII_Code |
1EH73XKR9N |
|
Has_Free_Acid_Or_Base_Form | ||
in_subset | ||
label |
Pirbuterol Acetate |
|
Legacy Concept Name |
Pirbuterol_Acetate |
|
Preferred_Name |
Pirbuterol Acetate |
|
prefixIRI |
NCIT:C47675 |
|
prefLabel |
Pirbuterol Acetate |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0724666 |
|
subClassOf |